Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
9.74M
-
Shares change
-
+308K
-
Total reported value, excl. options
-
$62.2M
-
Value change
-
+$1.86M
-
Number of buys
-
20
-
Number of sells
-
-17
-
Price
-
$6.38
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q4 2018
52 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q4 2018.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.74M shares
of 27.7M outstanding shares and own 35.18% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4M shares), venBio Select Advisor LLC (1.11M shares), 683 Capital Management, LLC (971K shares), Opaleye Management Inc. (900K shares), EVENTIDE ASSET MANAGEMENT, LLC (720K shares), BlackRock Inc. (562K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (365K shares), PUTNAM INVESTMENTS LLC (262K shares), STATE STREET CORP (162K shares), and UNITED SERVICES AUTOMOBILE ASSOCIATION (154K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.